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Abstract
We develop statistical methods for detecting rare variants that are associated with quantitative traits. We propose
two strategies and their combination for this purpose: the iterative regression strategy and the extreme values
strategy. In the iterative regression strategy, we use iterative regression on residuals and a multimarker association
test to identify a group of significant variants. In the extreme values strategy, we use individuals with extreme trait
values to select candidate genes and then test only these candidate genes. These two strategies are integrated
into a hybrid approach through a weighting technology. We apply the proposed methods to analyze the Genetic
Analysis Workshop 17 data set. The results show that the hybrid approach is the most powerful approach. Using
the hybrid approach, the average power to detect causal genes for Q1 is about 40% and the powers to detect
FLT1 and KDR are 100% and 68% for Q1, respectively. The powers to detect VNN3 and BCHE are 34% and 30% for
Q2, respectively.
Background
Evidence is increasingly showing that complex diseases
are caused by both common and rare variants [1-3]. Sta-
tistical methods to detect common variants have been
well developed. However, these methods are not optimal
for detecting rare variants. Recently, several methods
have been proposed to detect rare variants, including
the combined multivariate and collapsing (CMC)
method [4] the Markov chain (MC) method [5], the
cohort allelic sums test (CAST) [6], and its weighted
version, the weighted-sum (WS) method [7]. These
methods essentially test one gene at a time. Because
complex diseases are caused by many genes, the existing
methods may lose power.
In this paper, we develop two strategies to search for
both common and rare variants in multiple genes: itera-
tive regression and extreme values. A hybrid approach
of these two strategies is also explored to improve
power. In the iterative regression strategy, common sin-
gle-nucleotide polymorphisms (SNPs) and rare variant
combinations are tested first. Then a best variant is
selected. The regression is repeated against the residual
to discover potential variants. A score test [8] is used
for all the selected SNPs to determine whether we
should continue the iterative process. In the extreme
values strategy, we use the individuals with the top 5%
value of the quantitative trait to select candidate genes
and then use the score test [8] to test each candidate
gene. We apply the proposed methods to the Genetic
Analysis Workshop 17 (GAW17) data set to detect
genes that are associated with two quantitative traits.
Methods
Data preparation
The variants of the GAW17 data set are divided into
common and rare. We define a variant as rare if its
minor allele frequency (MAF) is less than 0.01. Within
each gene, we collapse all rare variants to obtain a rare
variant combination (RVC) [4]. For an RVC, we code
the genotype for the ith individual as 1 if the ith
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RVC; otherwise the genotype is coded as 0. For a com-
mon SNP with two alleles a and A,w ed e f i n et h e
numerical code of genotype for the ith individual as xi =
0, 1, or 2 for genotype aa, aA,o rAA, respectively. The
GAW17 data set contains genotypes at 24,487 SNPs in
3,205 genes on chromosomes 1–22 with 209 case sub-
jects and 488 control subjects. In this study, the genes
are removed from the data set if they do not have non-
synonymous SNPs. After the removal of 1,009 genes
from the data set, 2,196 genes are used for the analysis
in the following step. Then, synonymous SNPs in the
remaining 2,196 genes are deleted. The original GAW17
data set is transformed into a new data set G,w h i c h
includes 4,711 common SNPs or RVCs.
Iterative regression strategy
We propose the iterative regression strategy to identify a
group of significant common SNPs or RVCs. For this
method, we need a multimarker test. We propose to use
the score test given by Chapman et al. [8]. Let xi =( xi1,
…, xik)
T,a n dl e tyi denote the numerical code of the
multimarker genotype and the trait value of the ith indi-
vidual, where i =1 ,…, N and N i st h es a m p l es i z e .T o
test the null hypothesis of no association between the k
m a r k e r sa n dt h et r a i t ,w eu s et h es c o r et e s ts t a t i s t i c
given by:
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and:
Vy V =⋅ var( ) . 1 (5)
The score test statistic S asymptotically follows a chi-
square distribution with k degrees of freedom.
F o rag i v e nm a r k e rc u t o f fv a l u eL and a significance
level a, the algorithm includes the following steps:
Step 1. Use an L step procedure (step 11, step 12, …,
step 1L) to select L candidate SNPs or RVCs, denoted
v1, …, vL.I ns t e p1 j, a SNP or RVC that has the highest
correlation with trait values is selected and denoted vj.
Then, we update the trait value by residual:
yy v j *, =− − bb 01 (6)
where ˆ b0 and ˆ b1 are the least-squares estimators of
b0 and b1 in the linear model:
yv ii j i =+ + bb e 01 . (7)
Step 2. Let A1, …, AL denote the L candidate SNP
sets, where Ai ={ v1, …, vi}. The score test is used to test
association of each Ai.T h er a wp-value pi is calculated
by using a chi-square distribution and the adjusted p-
value qi is computed by using a permutation test. The
SNP set with the smallest adjusted p-value is the final
candidate SNP set. The final candidate SNP set is
denoted Af.
Step 3. Use a permutation test to evaluate the overall
p-value of Af. Denote the overall p-value as poverall.I f
poverall <a, the final significant SNP set is the final can-
didate SNP set Af. Otherwise, the final significant SNP
set is empty.
Using a standard permutation procedure, we obtain
poverall through another layer of permutation. We use a
permutation procedure recently proposed by Ge et al.
[9] to evaluate adjusted p-values and the overall p-
value at the same time using one layer of permutation.
The permutation procedure includes the following
steps:
Step 1. Generate S (say, 1,000) permuted data sets. In
each permutation, we randomly shuffle trait values. For
each permuted data set, search for the L candidate SNP
sets by using the same procedure. For the sth permuted
data set (the 0th data set is the real data set), denote the
L candidate SNP sets by As1, …, AsL and the associated
raw p-values by Ps1, …, PsL. Then, the adjusted p-value
corresponding to the candidate SNP set Al is estimated
by:
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where I(·) is the indicator function. We choose the
SNP set with the smallest adjusted p-value,
pp p p L 00 1 0 2 0 = min( , , , ),  (9)
as the final candidate SNP set.
Step 2. To evaluate the overall p-value of the final
candidate SNP set, we first adjust the raw p-values Ps1,
…, PsL for the sth permuted data, s =1 ,…, S.T h e
adjusted value of Psl is given by:
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Let:
pp p ss s L = min{ , , }. 1  (11)
Then, the overall p-value of the final candidate SNP
set is given by:
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Extreme values strategy
Intuitively, for a quantitativ et r a i tt h a th a sap o s i t i v e
relation with a disease, an individual with more causal
mutations will have a higher trait value. Therefore we
propose to use an extreme values strategy to select can-
didate genes for testing association with rare variants.
The extreme values strategy includes two steps.
Step 1. We select candidate genes using individuals
with extreme trait values (top 5% in this study). In
detail, we first select a group of individuals with extreme
trait values and denote this group of individuals by EX =
{i: yi >C}. For a gene with an RVC, let xi denote the
numerical code of genotype of the ith individual. Then,
we define this gene as candidate gene if
max { } iE X i x ∈ =1. In other words, we define a gene as a
candidate gene if at least one individual in EX has at
least one rare mutation within the RVC of this gene.
Step 2. We apply the score test to each of the candi-
date genes. For a given significance level a, a candidate
gene is declared significant if the p-value is less than a/
n, where n is the number of candidate genes.
Hybrid approach
The iterative regression and extreme values strategies are
different. One is a gene-based method and the other is a
SNP-based method. The integration of the two methods
may improve the power to detect association. Thus we
propose a hybrid approach. The hybrid approach ends
with a group of significant genes and SNPs or RVCs. For
a given significance level a,l e tAa denote the group of
significant SNPs provided by the iterative regression
strategy and Ba denote the group of significant genes
provided by the extreme values strategy. Then, the hybrid
approach ends with the union of Aa/2 and Ba/2.
Results
We use the three proposed methods and the CMC
method to analyze the GAW17 data set. Before the data
analysis, we already knew the answers. The first step of
data analysis is to adjust trait values for covariates by
assuming the linear model:
yxx kk =+ + + + bb b e 01 1  , (13)
where y is the trait value and x1, …, xk are the covari-
ates. In this application, we consider Age, Sex, and
Smoking history as covariates. In the following discus-
sion, we use residuals as trait values.
For evaluating the performance of the four methods,
we first consider type I error rates. To evaluate type I
error rates, we permute trait values in each of the 200
replications. The estimated type I error rates of the four
methods based on permuted trait values are given in
Figure 1. For 200 replicated samples, the standard devia-
tion of type I error rates is [0.05(0.95)/200]
1/2 ≈ 0.015,
and the 95% confidence interval (CI) is (0.02, 0.08) for
the nominal level of 0.05. From Figure 1, we can see
that type I error rates for all four methods are within
the 95% CI for Q2, whereas type I error rates for all
four methods are significantly higher than the nominal
level of 0.05 for Q1. This is because of the inflated type
I errors caused by outliers, which is depicted in the box-
plot and normal quantile-quantile (Q-Q) plot for Q1
shown in Figure 2. To delete the effect of outliers, we
rank Q1 and apply an inverse normal transformation.
Based on the transformed Q1, type I error rates for all
four methods are within the 95% CI (Figure 1). In the
power comparisons, we use transformed Q1.
Quantitative trait Q1 is influenced by 9 genes, and Q2
is affected by 13 genes. For the purpose of power com-
parisons, we calculate the average power to detect the 9
causal genes of Q1 (called power for Q1) and the average
power to detect the 13 causal genes of Q2 (called power
for Q2). The power for Q1 and the power for Q2 of the
four methods are summarized in Figure 3. This figure
shows that the patterns of power comparison for Q1 and
Figure 1 Type I errors of the four methods Type I error at a
nominal level of 0.05. T-Q1 denotes the value of Q1 after ranking
and an inverse normal transformation.
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Page 3 of 5Q2 are consistent; that is, from the most powerful to the
least powerful, the methods are the hybrid approach, the
iterative regression strategy, the extreme values strategy,
and the CMC method. This pattern is not hard to under-
stand because the hybrid and iterative regression
approaches can consider multiple genes simultaneously,
whereas the extreme values and CMC methods consider
one gene at a time. We further compare power of the
hybrid approach and the CMC method by evaluating the
power of detecting each of the causal genes of Q1 and
Q2 (Figure 4). We learn from Figure 4 that the hybrid
approach is consistently more powerful than the CMC
method for detecting the 22 causal genes.
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Figure 2 Boxplot and Q-Q plot of Q1
Figure 3 Power of the four methods
Figure 4 Powers to detect causal genes using the hybrid and
CMC methods Power for (a) Q1 and (b) Q2.
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New sequencing technologies that allow researchers to
sequence parts of the genome—o r ,i nt h ef u t u r e ,t h e
whole genome—of large groups of individuals have
made rare variant association studies feasible. However,
statistical methods to test association between rare var-
iants and phenotypes are still underdeveloped. Existing
methods that essentially test one gene at a time may
lose power to detect complex disease genes because
complex diseases are presumed to be caused by many
genes. In this paper, we have developed three novel
methods: the iterative regression strategy, the extreme
values strategy, and the hybrid approach. The iterative
regression strategy can test multiple genes simulta-
neously, whereas the extreme values strategy can delete
less important genes and thus makes the problem of
multiple testing less severe. The hybrid approach is the
combination of the two strategies. Analysis using the
GAW17 data set shows that all three proposed methods
are more powerful than the CMC method, one typical
existing method used to test rare variant association. In
this study, we collapse all rare variants within one gene
into a single variant and analyze this variant together
with common variants. We can also use other collapsing
methods, such as the weighted-sum method [7], to col-
lapse both rare and common variants within one gene
into a single variant and apply our methods to the col-
lapsed variants. One problem left for the iterative
regression method is choosing an appropriate marker
cutoff value L (number of candidate SNPs in step 1). If
L is too small, the iterative regression method may lose
power because it cannot include all causal genes. If L is
too large, the iterative method may also lose power
because noise terms are included. Further investigation
is needed for choosing the optimal value of L.
Conclusions
We propose three methods for detecting both rare and
common variants. Application to the GAW17 data set
shows that all three proposed methods are more power-
ful than the CMC method, one typical existing method
used to test rare variant association.
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